GSK to settle 80,000 Zantac cases for up to $2.2 billion
The deal settles 80,000 US court cases related to allegations that Zantac was contaminated with a suspected carcinogen.
Tomas Kauer - News Moderator 
The deal settles 80,000 US court cases related to allegations that Zantac was contaminated with a suspected carcinogen.
